Drugs / AJU-S56
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06337981 | Nov 2021 → Jun 2022 | dry eye syndrome | AJU Pharm Co., Ltd. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06291194 | Nov 2023 → May 2024 | dry eye syndrome | AJU Pharm Co., Ltd. | Unknown | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2026-09-11 | Aju Pharm | Regulatory 아주약품, 국내 44호 신약 ‘라티카점안액5%’ 품목허가 획득 : 아주약품(주) ajupharm.co.kr ↗
아주약품이 지엘팜텍과 공동 개발한 안구건조증 치료제 ‘라티카점안액5%(레코플라본수화물, 코드명 AJU-S56)’의 품목허가를 2026년 9월 8일 획득했습니다. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2026-09-11 | Aju Pharm | 아주약품, 국내 44호 신약 ‘라티카점안액5%’ 품목허가 획득 : 아주약품(주) ajupharm.co.kr ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AJU-S56 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06337981 ↗ |